ESSA Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.10.18	EPIX Soars, OASM Turning Heads, LQDA Jumps 96% In 1 Month (RTTNews)
05.09.18	MNKD Takes Giant Leap, REPH On Watch, ALRN To Report Study Data In Q4 (RTTNews)
15.05.18	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 (PR Newswire)
15.05.18	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 (PR Newswire)
10.05.18	Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements (PR Newswire)
10.05.18	Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements (PR Newswire)
02.05.18	HTBX Up 265% In 2 Days, AVGR Heartened, SCPH Faces FDA In June, THC Healthy (RTTNews)
26.04.18	ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 (PR Newswire)
26.04.18	ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 (PR Newswire)
25.04.18	ESSA Pharma Inc. Announces Completion of Share Consolidation (PR Newswire)
25.04.18	ESSA Pharma Inc. Announces Completion of Share Consolidation (PR Newswire)
24.04.18	ESSA Pharma Enhances R&D Capabilities with Two New Key Hires (PR Newswire)
24.04.18	ESSA Pharma Enhances R&D Capabilities with Two New Key Hires (PR Newswire)
20.04.18	ESSA Pharma Inc. Announces Share Consolidation (PR Newswire)
20.04.18	ESSA Pharma Inc. Announces Share Consolidation (PR Newswire)
29.03.18	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders (PR Newswire)
29.03.18	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders (PR Newswire)
19.03.18	Cognetivity Neurosciences Ltd. Announces Listing on the CSE and Grant of Options (PR Newswire)
15.03.18	New Flyer Industries Inc. Announces First Quarter 2018 Dividend (PR Newswire)
23.02.18	ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants (PR Newswire)
23.02.18	ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants (PR Newswire)
14.02.18	Radiation temporaire de cinq ans de Anne Voyer-Sirois (PR Newswire)
13.02.18	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 (PR Newswire)
13.02.18	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 (PR Newswire)
05.02.18	GreenSpace Brands Inc. to Host Third Quarter 2018 Results Conference Call on February 15th, 2018 (PR Newswire)
26.01.18	ESSA to Present at Noble Capital Markets' NobleCon14 (PR Newswire)
26.01.18	ESSA to Present at Noble Capital Markets' NobleCon14 (PR Newswire)
26.01.18	ESSA Announces Management Team Change (PR Newswire)
26.01.18	ESSA Announces Management Team Change (PR Newswire)
17.01.18	ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule (PR Newswire)
17.01.18	ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule (PR Newswire)
09.01.18	ESSA Completes US$21 Million Equity Offering (PR Newswire)
14.12.17	Canada Infrastructure Bank names Bruno Guilmette interim Chief Investment Officer (PR Newswire)
12.12.17	ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017 (PR Newswire)
12.12.17	ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017 (PR Newswire)
24.11.17	La Monnaie royale canadienne présente ses résultats du troisième trimestre de 2017 (PR Newswire)
22.11.17	ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX (PR Newswire)
22.11.17	ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX (PR Newswire)
16.11.17	Marapharm Ventures Inc. provides production update at Las Vegas facilities (PR Newswire)
15.11.17	Mattamy Homes Purchases Royal Oaks Building Group of Raleigh, NC (PR Newswire)
07.11.17	College faculty to vote from November 14 to November 16 (PR Newswire)
07.11.17	CTV Reveals First 10 Aspiring Artists Selected to Appear on CTV's New Original Music Series and International TV Format, THE LAUNCH (PR Newswire)
04.11.17	Ian Millar Dominates Canadian Show Jumping Championship (PR Newswire)
23.10.17	Eco Oro Receives Final Approval to List on CSE (PR Newswire)
20.10.17	Entente de principe entre Unifor et Medical Laboratories of Windsor (PR Newswire)
19.10.17	Road Closure Notice - Sunday, October 22, 2017 (PR Newswire)
17.10.17	InMed Updates Pain Program (PR Newswire)
10.10.17	Invitation du curateur public du Québec - Lancement du nouveau Mandat de protection (PR Newswire)
04.10.17	Trans Mountain Signs Contracts for Expansion Project (PR Newswire)
04.10.17	Élections municipales 2017 - Les engagements de l'Équipe Denis Coderre pour Montréal en matière d'itinérance (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu ESSA Pharma Inc

Aktien Top/Flop

Meistgelesene Nachrichten